• New US studies demonstrate Idylla™ allows rapid first assessment of most common EGFR mutations preceding next-generation sequencing

    Wednesday February 3rd 2021

  • argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis

    Tuesday February 2nd 2021

  • Euronext Biotech Barometer H2 2020

    Monday February 1st 2021

  • Novalis Biotech announces acquisition of Doc.ai by Sharecare

    Monday February 1st 2021

  • Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European

    Wednesday January 27th 2021

  • Nomination of Christophe Maréchal as interim CEO

    Friday January 22nd 2021

  • Biotalys submits first protein-based biocontrol registration package to the EPA

    Friday January 22nd 2021

  • Targeting Tau to keep neurons connected

    Thursday January 21st 2021

  • Your news here?

  • reMYND extends Series B funding to EUR 24 million

    Thursday January 21st 2021

  • NICE recommends Jyseleca® (filgotinib) on NHS in landmark decision for rheumatoid arthritis

    Thursday January 21st 2021

  • Blue Matter announces acquisition of AIM, a leading European supply chain consulting firm

    Wednesday January 20th 2021

Strategic Partners